Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in GMAB — Genmab A/S

CIK 1423053 MIAMI, FL
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$68,015,471
+$68,015,471 QoQ
Shares Held
2,475,991
Ownership
0.403%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#13
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Derivatives in GMAB

reported options exposure · as of Jun 30, 2026
CallValue
$8,578,881
CallShares
312,300
PutValue
$1,244,391
PutShares
45,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. GMAB ranks #23 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in GMAB

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,015,471 2,475,991
2026-06-30 $8,578,881 312,300
2026-06-30 $1,244,391 45,300
2026-03-31 $4,628,175 172,500
2025-12-31 $406,560 13,200
2025-12-31 $588,341 19,102
2025-12-31 $828,520 26,900
2025-09-30 $312,834 10,200
2025-09-30 $1,578,676 51,473
2025-09-30 $920,100 30,000
2025-06-30 $553,688 26,800
2025-06-30 $73,739,340 3,569,184
2025-06-30 $378,078 18,300
2025-03-31 $943,756 48,200
2025-03-31 $86,673,884 4,426,654
2025-03-31 $744,040 38,000
2024-12-31 $267,136 12,800
2024-12-31 $327,659 15,700
2024-12-31 $64,533,045 3,092,144
2024-09-30 $199,916 8,200
2024-09-30 $31,690,488 1,299,856
2024-09-30 $248,676 10,200
2024-06-30 $31,937,414 1,270,888
2024-06-30 $326,690 13,000
2024-06-30 $170,884 6,800
2024-03-31 $1,439,806 48,138
2024-03-31 $400,794 13,400
2024-03-31 $412,758 13,800
2023-12-31 $4,951,788 155,521
2023-12-31 $372,528 11,700
2023-12-31 $89,152 2,800
2023-09-30 $373,862 10,600
2023-09-30 $102,283 2,900
2023-09-30 $8,638,010 244,911
2023-06-30 $10,381,822 273,134
2023-06-30 $174,846 4,600
2023-06-30 $129,234 3,400
2023-03-31 $1,295,168 34,300
2023-03-31 $313,408 8,300
2023-03-31 $16,306,768 431,853
2022-12-31 $17,000,905 401,154
2022-12-31 $127,140 3,000
2022-12-31 $93,236 2,200
2022-09-30 $5,561,703 173,100
2022-09-30 $10,140,035 315,594
2022-06-30 $7,777,715 239,388
2022-06-30 $2,647,935 81,500
2022-03-31 $4,466,710 123,458
2022-03-31 $846,612 23,400
2021-12-31 $261,096 6,600